To quote Stephen:
”I think the key there is understanding the size of the effective size of that grant post tax compared to the CapEx requirement and understanding what conditions and ability to put other funding alongside a grant might look like compared to what we know about the DOE loan process, the ATVM loan process that we're already working through.So, as per comments earlier in the call, the DOE loan application that we've put in alongside the grant is for a higher amount than what would be effective from the grant. And we'll work through those processes with the DOE and understand what options may be available to us and obviously we're also looking at other funding options in conjunction with those for the full capital amount”.
I don’t believe the loan will attract any tax, hence the reason a bigger loan may be a more flexible option. They are also looking at “other funding options” not sure if they mean some other option from the convertible notes.
- Forums
- ASX - By Stock
- SYR
- Ann: March 2023 Quarterly Activities Presentation
Ann: March 2023 Quarterly Activities Presentation, page-128
Featured News
Add SYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $232.8M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 22.5¢ | $1.802M | 7.921M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 1034048 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 443295 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 1034048 | 0.220 |
11 | 2519858 | 0.215 |
18 | 477024 | 0.210 |
3 | 320000 | 0.205 |
34 | 800565 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 443295 | 9 |
0.235 | 226020 | 5 |
0.240 | 169251 | 5 |
0.245 | 77688 | 5 |
0.250 | 98737 | 5 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online